These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Dai X, Makaryus AN, Makaryus JN, Jauhar R. Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228 [Abstract] [Full Text] [Related]
3. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations. Moussa ID, Colombo A. Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1047-54. PubMed ID: 19626692 [Abstract] [Full Text] [Related]
4. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. May AE, Geisler T, Gawaz M. Thromb Haemost; 2008 Mar 01; 99(3):487-93. PubMed ID: 18327396 [Abstract] [Full Text] [Related]
5. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, CREDO Investigators. Am Heart J; 2009 Feb 01; 157(2):369-74. PubMed ID: 19185647 [Abstract] [Full Text] [Related]
6. Noncardiac surgery and bleeding after percutaneous coronary intervention. To AC, Armstrong G, Zeng I, Webster MW. Circ Cardiovasc Interv; 2009 Jun 01; 2(3):213-21. PubMed ID: 20031718 [Abstract] [Full Text] [Related]
7. Gastrointestinal bleeding after percutaneous coronary intervention. Tanigawa T, Watanabe T, Nadatani Y, Otani K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T. Digestion; 2011 Jun 01; 83(3):153-60. PubMed ID: 21266809 [Abstract] [Full Text] [Related]
8. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Helft G, Gilard M, Le Feuvre C, Zaman AG. Nat Clin Pract Cardiovasc Med; 2006 Dec 01; 3(12):673-80. PubMed ID: 17122800 [Abstract] [Full Text] [Related]
9. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Yan BP, Gurvitch R, Ajani AE. Cardiovasc Revasc Med; 2006 Dec 01; 7(3):155-8. PubMed ID: 16945822 [Abstract] [Full Text] [Related]
10. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA. Am J Manag Care; 2009 Mar 01; 15(2 Suppl):S42-7. PubMed ID: 19355808 [Abstract] [Full Text] [Related]
11. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R. Am J Cardiol; 2008 Dec 15; 102(12):1614-7. PubMed ID: 19064014 [Abstract] [Full Text] [Related]
12. Potential Interaction between clopidogrel and proton pump inhibitors. Howard PA, Vacek JL. Am J Cardiovasc Drugs; 2009 Dec 15; 9(6):353-9. PubMed ID: 19929033 [Abstract] [Full Text] [Related]
13. Drug-eluting stent thrombosis. Stähli BE, Camici GG, Tanner FC. Ther Adv Cardiovasc Dis; 2009 Feb 15; 3(1):45-52. PubMed ID: 19124388 [Abstract] [Full Text] [Related]
14. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E. Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050 [Abstract] [Full Text] [Related]
15. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation. Latib A, Morici N, Cosgrave J, Airoldi F, Godino C, Brambilla N, Chieffo A, Bonizzoni E, Carlino M, Bedogni F, Montorfano M, Sangiorgi GM, Briguori C, Colombo A. Am J Cardiol; 2008 Dec 01; 102(11):1477-81. PubMed ID: 19026299 [Abstract] [Full Text] [Related]
16. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. Hsu PI. J Gastroenterol Hepatol; 2012 Apr 01; 27(4):654-61. PubMed ID: 22283743 [Abstract] [Full Text] [Related]
17. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ. Am J Cardiol; 2008 Dec 15; 102(12):1618-23. PubMed ID: 19064015 [Abstract] [Full Text] [Related]
18. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK. J Invasive Cardiol; 2006 Apr 15; 18(4):162-4. PubMed ID: 16729401 [Abstract] [Full Text] [Related]
19. Perioperative management of the patient with a coronary stent. Popescu WM. Curr Opin Anaesthesiol; 2010 Feb 15; 23(1):109-15. PubMed ID: 19901828 [Abstract] [Full Text] [Related]
20. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Martín-Yuste V, Brugaletta S, Sabaté M, Alfonso F, Capote ML, De La Torre JM, Ruíz-Lera M, Sanmiguel D, Cárdenas M, Pujol B, Baz JA, Iñiguez A, Trillo R, González-Béjar O, Casanova J, Sánchez-Gila J, García-Dorado D. Circulation; 2010 Sep 07; 122(10):1017-25. PubMed ID: 20733100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]